Immune Modulation During Palynziq® Treatment in Adults (IMPALA)

Clinical trial NCT07477691 · RECRUITING

Trial details

NCT number: NCT07477691
Sponsor: BioMarin Pharmaceutical
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Phenylketonuria

Start date: 2026-05-29
Primary completion: 2027-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.